Concepedia

David Diuguid

DD

14

Publications

1.6K

Citations

13

H-Index

1986

Active since

Affiliations

Columbia University(Current)

NewYork–Presbyterian Hospital

New York Hospital Queens

University of Chicago

Ramathibodi Hospital

David Diuguid is an author at Columbia University specializing in medicine, immunology, and pathogenesis.

Top concepts

Publications per year

1986–2022

14

Publications

14

A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease

Elliott Vichinsky, Carolyn Hoppe, Kenneth I. Ataga et al. · New England Journal of Medicine · 2019 · 581 citations · Full text

American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19

Adam Cuker, Eric Tseng, Robby Nieuwlaat et al. · Blood Advances · 2021 · 412 citations · Full text

Molecular basis of hemophilia B: a defective enzyme due to an unprocessed propeptide is caused by a point mutation in the factor IX precursor.

David Diuguid, Marie‐Josèphe Rabiet, Bruce Furie et al. · Proceedings of the National Academy of Sciences · 1986 · 131 citations · Full text

, , +15

American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: July 2021 update on postdischarge thromboprophylaxis

Adam Cuker, Eric Tseng, Robby Nieuwlaat et al. · Blood Advances · 2021 · 85 citations · Full text

American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: January 2022 update on the use of therapeutic-intensity anticoagulation in acutely ill patients

Adam Cuker, Eric Tseng, Robby Nieuwlaat et al. · Blood Advances · 2022 · 70 citations · Full text

Rows per page

1–5 of 14